98 related articles for article (PubMed ID: 2277209)
21. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
Liu LY
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
23. [Significance of second look surgery in the therapy of ovarian cancer].
Sasaki H; Ochiai K; Terashima Y
Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis in ovarian cancer as a function of the results of the second-look laparatomy].
Varette C; de Gramont A; Louvet C; Gonzalez-Canali G; Krulik M; Drolet Y; Pigné A; Marpeau L; Barrat J; Gallot D
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):222-7. PubMed ID: 2723353
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis and prognostic factor analysis epithelial ovarian cancer].
Wen H; Sun W; Guo Y
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):159-62. PubMed ID: 9596891
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of preoperative and postoperative chemotherapy in the treatment of advanced ovarian cancer].
Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):647-52. PubMed ID: 2671201
[TBL] [Abstract][Full Text] [Related]
28. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic, clinical and histological factors related to the survival of patients with advanced ovarian carcinoma.
Kauppila A; Kivinen S; Mäkilä UM; Järvinen PA
Ann Chir Gynaecol; 1981; 70(3):91-5. PubMed ID: 7325582
[TBL] [Abstract][Full Text] [Related]
30. [Multimodal treatment for advanced, ovarian cancer patients with poor performance status--its effectiveness and limitations].
Shimizu Y; Tatsuki Y; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Dec; 44(12):1551-8. PubMed ID: 1484219
[TBL] [Abstract][Full Text] [Related]
31. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up.
Charak BS; Agarwala S; Gopal R; Advani SH; Nadkarni KS; Pai VR; Saikia TK; Desai PB
Indian J Cancer; 1989 Jun; 26(2):85-91. PubMed ID: 2592001
[TBL] [Abstract][Full Text] [Related]
33. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
34. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
[TBL] [Abstract][Full Text] [Related]
35. [Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute].
Pautier P; Rey A; Michel G; Castaigne D; Rochard F; Duvillard P; Haie-Meder C; Curcio P; Benedetti-Richard L; Lhommé C
Bull Cancer; 1997 Feb; 84(2):147-54. PubMed ID: 9180837
[TBL] [Abstract][Full Text] [Related]
36. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
Ohta M; Tomoda Y; Kano T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
[TBL] [Abstract][Full Text] [Related]
37. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
38. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
Li M; Huang X
Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
[TBL] [Abstract][Full Text] [Related]
39. [Results of cisplatin-based polychemotherapy and analysis of prognostic factors in ovarian cancer. Apropos of 106 cases].
Maloisel F; Dufour P; Bergerat JP; Bellocq JP; Duclos B; Boilletot A; Herbrecht R; Dellenbach P; Renaud R; Ritter P
Bull Cancer; 1989; 76(10):1083-93. PubMed ID: 2635636
[TBL] [Abstract][Full Text] [Related]
40. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]